Advertisement
UK markets close in 10 minutes
  • FTSE 100

    8,314.78
    +101.29 (+1.23%)
     
  • FTSE 250

    20,374.56
    +210.02 (+1.04%)
     
  • AIM

    775.63
    +4.10 (+0.53%)
     
  • GBP/EUR

    1.1643
    -0.0017 (-0.14%)
     
  • GBP/USD

    1.2549
    -0.0015 (-0.12%)
     
  • Bitcoin GBP

    50,829.76
    +380.08 (+0.75%)
     
  • CMC Crypto 200

    1,330.29
    -34.84 (-2.55%)
     
  • S&P 500

    5,195.13
    +14.39 (+0.28%)
     
  • DOW

    38,932.92
    +80.65 (+0.21%)
     
  • CRUDE OIL

    78.17
    -0.31 (-0.40%)
     
  • GOLD FUTURES

    2,326.70
    -4.50 (-0.19%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     
  • DAX

    18,426.13
    +250.92 (+1.38%)
     
  • CAC 40

    8,070.89
    +74.25 (+0.93%)
     

MetLife Full Year 2022 Earnings: Misses Expectations

MetLife (NYSE:MET) Full Year 2022 Results

Key Financial Results

  • Revenue: US$69.9b (down 1.7% from FY 2021).

  • Net income: US$2.35b (down 63% from FY 2021).

  • Profit margin: 3.4% (down from 8.9% in FY 2021). The decrease in margin was primarily driven by higher expenses.

  • EPS: US$2.91 (down from US$7.36 in FY 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

MetLife Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 2.5%.

Looking ahead, revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Insurance industry in the US.

ADVERTISEMENT

Performance of the American Insurance industry.

The company's shares are down 3.1% from a week ago.

Risk Analysis

We should say that we've discovered 2 warning signs for MetLife that you should be aware of before investing here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here